Key CML research from ASH 2010
18 Feb 2011
Key CML research from ASH 2010
Advances in the treatment of CLL
The role of plasma cell biology in multiple myeloma
Key multiple myeloma research from ASH 2010
CLL related research from ASH 2010
The DASISION chronic myeloid leukaemia trial
Key lymphoma research from ASH 2010
The importance of myelodysplastic syndrome diagnosis
Haematological cancers in the elderly
ENESTnd trial comparing nilotinib and imatinib as first line CML therapy
Signalling pathways as a target for cancer therapies
Inotuzumab ozogamicin therapy for indolent B-cell non-Hodgkin's lymphoma